Navigation Links
Industry-First Telephone for Health Care Developed by CyraCom
Date:9/26/2007

Hospital Trials Complete for Limited-English Interpretation

TUCSON, Ariz., Sept. 26 /PRNewswire/ -- Clinically relevant timing, especially important for serving limited-English speaking patients in hospitals and health care facilities, is now markedly enhanced with the development of the industry's first dual-handset cordless phone, ClearLink(TM) Cordless.

Precedent-setting, as was CyraCom's invention of its patented dual-handset phone now known as ClearLink(TM), this new cordless phone is specifically designed for medical interpretation in health care settings. ClearLink(TM) Cordless also is patented, with an additional patent pending.

The ClearLink(TM) Cordless mobile dual-handsets provide access for language interpretation service in nearly any patient care environment. It is particularly well-suited for use in emergency, labor and delivery, physical therapy and occupational medicine departments, as well as out-patient clinics. It provides improved access to over-the-phone interpretation in areas of health care facilities with limited phone access. Another advantage of its mobility is that it enhances workflow by allowing caregivers to sequentially treat patients with a common language need while connected to the same interpreter.

ClearLink(TM) Cordless has belt clips and headsets to give caregivers more freedom of movement. Its high quality speakerphone features, including a handset volume control, enable hands-free communication. The smooth surface has a specially designed coating unique to ClearLink(TM) that helps ensure effective infection control.

"This new cordless phone can easily be set up for interpretation service when clinicians need it, and virtually anywhere," said CyraCom CEO Michael Greenbaum. CyraCom introduced its first patented dual-handset phone in 1995.

Leading hospitals nationwide have trialed ClearLink(TM) Cordless as part of CyraCom's ongoing program of bringing innovative products and service
'/>"/>

SOURCE CyraCom
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. The ABCs of telephone regulation in Wisconsin
2. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
3. Web-based reporting credited with states top healthcare ranking
4. Visions, Part II: Preizler sees IT leading incremental health system change
5. Visions: Preizler offers insurers perspective on healthcare IT
6. Federal bill would set healthcare IT standards
7. IRS ruling could speed healthcare technology adoption
8. Bill would provide federal aid for healthcare IT
9. Cardinal Health likes growth potential of Viasys NeuroCare Group
10. DHC 2007: Controlling health IT costs the key to capturing value
11. Siemens health services president calls IT benefits unassailable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... JUPITER, Fla., Dec. 14 Dyadic International, ... it has extended its collaboration with The Scripps ... with Scripps to re-annotate the genome of Dyadic,s ... agreement is a continuation of the successful relationship ... 2006 when Dyadic engaged Scripps to annotate the ...
(Date:12/14/2009)... CARLOS, Calif., Dec. 14 Nektar Therapeutics ... Winger has been appointed to serve on its ... biopharmaceutical industry leader with over 35 years of ... ,, "Dennis brings to Nektar extensive industry perspective ... said Howard W. Robin, President and CEO of ...
(Date:12/11/2009)... -- Dendreon Corporation (Nasdaq: DNDN ) announced ... public offering have exercised in full their option ... stock at the public offering price of $24.75 ... increases the size of the offering to an ... Dendreon expects to receive net proceeds from the ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer therapeutics company, ... the,US, the Tulane Cancer Center, New Orleans, ... clinical study of Alpharadin in men with,castration-resistant ... has metastasized to the skeleton. , ... SYMptomatic Prostate CAncer) study is a,double-blind, randomized, ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4
... ARLINGTON, Va., March 17 The 2008 Life ... Boston Waterfront Hotel on June,3, 2008 at a ... Leading market research firm,BioInformatics, LLC ( http://www.gene2drug.com ) ... this year,s awards., The annual awards honor ...
... Inc., a developer of advanced medical devices for ... that it has enrolled its,first patient in the ... prospective,multi-centered U.S. registry study of the company,s OmniWave(TM),Endovascular ... acute deep vein thrombosis (DVT). All patients enrolled ...
... 17 Alimera Sciences,and pSivida Ltd (Nasdaq: ... that,they have amended their license and collaboration agreement ... treatment for,diabetic macular edema (DME), and other Medidur ... profits of Medidur FA from 50 to 80,percent ...
Other Biology Technology:Life Science Industry Awards to Be Announced June 3, 2008 in Boston 2Life Science Industry Awards to Be Announced June 3, 2008 in Boston 3First Patient Enrolled in SONIC I Registry of OmniSonics Medical Technologies' OmniWave(TM) Endovascular System 2Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement 2Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement 3Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement 4
(Date:12/14/2009)... feature of humans. That,s until examples of tool use came ... of other mammals. Now, a report in the December 14th ... adds an octopus to the growing list of tool users. ... that the researchers call stilt walking. In it, the soft-bodied ... its eight arms rigid, and raises the whole assembly to ...
(Date:12/14/2009)... -- MODA Technology Partners, a global software company ... testing for the Pharmaceutical industry, today announced the ... generation mobile data acquisition platform. The latest release ... their regulated manufacturing processes. ,, MODA 3.0 ... Fully-Configurable Test Methods: Each test method in ...
(Date:12/13/2009)... have identified plant enzymes that may help to engineer ... use water more efficiently. The finding could help to ... , Plants take in the carbon dioxide they need ... of leaves. But for each molecule of the gas ... same openings. The pores can tighten to save water ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3TV Interferes With Infants Language Development 47700 1TV Interferes With Infants Language Development 47700 2Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 1Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 2Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 3Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 4Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 5Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 1Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 2
... in a population because predators detect common forms of prey ... BMC Ecology found that birds will target salamanders that ... response to alterations in the ratio of a distinguishing trait. ... with Kim Shook and Reuben Izally to study the effects ...
... and Hosting Services Enhances Law Enforcement Information SharingWALL, ... Bulletin Board: BKYI), a leader in finger-based biometric ... a strategic partnership with Nlets. Nlets is the ... network for the exchange of law enforcement, criminal ...
... scientists report for the first time on the only known ... frequencies are too high to be heard by humans. Known ... only on the Southeast Asian island of Borneo. , ... frequency, which exceeds the upper limit of sounds detectable by ...
Other Biology News:BIO-key(R) Enters Strategic Partnership With Nlets 2BIO-key(R) Enters Strategic Partnership With Nlets 3UCLA scientists discover ultrasonic communication among frogs 2UCLA scientists discover ultrasonic communication among frogs 3UCLA scientists discover ultrasonic communication among frogs 4
Mouse monoclonal antibody raised against a partial recombinant AATK. NCBI Entrez Gene ID = AATK...
... The JASCO Model AS-2055 and AS-2057 are ... productivity and,the highest possible level of precision. ... 384 well positions (microplate) for,laboratory automation and ... for 84 micro-vials or the standard rack ...
... ImmEdge Pen, a hydrophobic barrier pen for ... for use with frozen or paraffin-embedded tissue ... Pen provides a heat-stable, water-repellent barrier that ... sections, prevents mixing of reagents when differentially ...
Mouse monoclonal antibody raised against a partial recombinant VEGFB. NCBI Entrez Gene ID = VEGFB...
Biology Products: